Long noncoding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis

Authors

  • Lansheng Zhang Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Xia Zheng Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Anqi Shen Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Daojin Hua Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Panrong Zhu Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Caihong Li Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhengxiang Han Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

DOI:

https://doi.org/10.17305/bjbms.2021.5803

Keywords:

Breast cancer, RP11-70C1.3, chemoresistance, NRP-1, miR-6736-3p

Abstract

Chemoresistance remains a major obstacle for improving the clinical outcome of patients with breast cancer. Recently, long noncoding RNAs (lncRNAs) have been implicated in breast cancer chemoresistance. However, the function and underlying mechanism are still largely unknown. Using lncRNA microarray, we identified 122 upregulated and 475 downregulated lncRNAs that might be related to the breast cancer chemoresistance. Among them, RP11-70C1.3 was one of the most highly expressed lncRNAs. In breast cancer patients, high RP11-70C1.3 expression predicted poor prognosis. Knockdown of RP11-70C1.3 inhibited the multidrug resistance of breast cancer cells in vitro and in vivo. Further investigations revealed that RP11-70C1.3 functioned as a competing endogenous RNA (ceRNA) for miR-6736-3p to increase NRP-1 expression. Notably, the rescue experiments showed that both miR-6736-3p inhibitor and NRP-1 overexpression could partly reverse the suppressive influence of RP11-70C1.3 knockdown on breast cancer chemoresistance. In conclusion, our study indicated that lncRNA RP11-70C1.3 regulated NRP-1 expression by sponging miR-6736-3p to confer chemoresistance of breast cancer cells. RP11-70C1.3 might be a potential therapeutic target in enhancing the clinical efficacy of chemotherapy in breast cancer.

Citations

Downloads

Download data is not yet available.

Author Biography

  • Anqi Shen, Department of Radiotherapy, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

    Department of Radiotherapy

Long noncoding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis

Downloads

Additional Files

Published

01-02-2022

Issue

Section

Molecular Biology

Categories

How to Cite

1.
Long noncoding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis. Biomol Biomed [Internet]. 2022 Feb. 1 [cited 2024 Jul. 19];22(1):87-99. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/5803